Chronic Wound Management (eBook, PDF)
81,95 €
81,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
41 °P sammeln
81,95 €
81,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
41 °P sammeln
Als Download kaufen
Geschenk
Als Download kaufen
81,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
41 °P sammeln
Jetzt verschenken
81,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
41 °P sammeln
  • Format: PDF

This book describes how chronic wounds follow a completely different healing trajectory to acute wounds and discusses the factors associated with these poor healing trajectories. These factors include age, chronic inflammation, phenotypic changes in such cells as macrophages, fibroblasts, and keratinocytes, colder, alkaline wound milieu, wound related hypoxemia, and diabetes. Other factors implicated include reperfusion injury, poor patient compliance, presence of undiagnosed and therefore unmanaged biofilms and wound pain. The past decades have yielded reliable evidence-based guidelines and…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
This book describes how chronic wounds follow a completely different healing trajectory to acute wounds and discusses the factors associated with these poor healing trajectories. These factors include age, chronic inflammation, phenotypic changes in such cells as macrophages, fibroblasts, and keratinocytes, colder, alkaline wound milieu, wound related hypoxemia, and diabetes. Other factors implicated include reperfusion injury, poor patient compliance, presence of undiagnosed and therefore unmanaged biofilms and wound pain.
The past decades have yielded reliable evidence-based guidelines and standardized care, but the healing of diabetic foot wounds continues to be unpredictable notwithstanding these advances, while the recurrence rates are also high. The benefits of technology in wound diagnosis are evidence-based and the use of this technology also features in guidelines. However, the same argument cannot be extended to adjuvant devices to facilitate wound closure even though many devices potentially benefit wound healing.
Chronic Wound Management describes how innovation is based on technology that itself informs evidence, the gap between the evidence available, the performance of technology and how do we bridge this gap. It reviews the lessons learnt from the COVID-19 pandemic and whether traditional medicine systems offer us real or imaginary benefits. Consequently, this book is an important addition to the literature in the area and an essential read for all healthcare professionals working with these patients.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Raj Mani has substantial experience in research and clinical management of chronic wounds; his early work was focused on perfusion and tissue oxygenation which contributed initially to the diagnosis and subsequently to the management of wounds. This work interfaced first with developments in other centers and then with the Cochrane Wounds Group, which led to the establishment of a sound literature-base to mark the start of evidence based wound management. In recent years, he with international peers drew up guidelines for optimizing the use of technology in wound management. This book will address existing gaps in management and discuss probable causes and offer remedies for such gaps. Dr Mani has contributed to the advancement of wound management through publications in journals, book chapters and books: Raj also initiated the publication of a journal - the International Journal of Lower Extremity Wounds (IJLEW) - of which he was the Editor-in-Chief till 2018. IJLEW whichwas followed by another couple of journals (also from the UK) and books in this field formed a platform from which better clinical management and research from practice developed. This benefited practitioners (Tissue Viability Nurses, Podiatrists, doctors-in-training) as well as Specialists. Dr Mani worked mostly from the UK though his contributions have been recognized in Asia including China as well as in Europe and USA (through activities of professional societies.